https://ki.se RSS News Listing https://news.ki.se/seeking-new-treatments-for-glaucoma Glaucoma is the most common cause of irreversible blindness worldwide. Pete Williams wants to find new ways of treating this disease by protecting and restoring nerve cells in the eye. Meet one of the new professors of Karolinska Institutet who will participate in this year's installation ceremony at Aula Medica on 9 October. Wed, 24 Sep 2025 10:00:15 +0200 https://news.ki.se/ki-and-st-erik-eye-hospital-expand-collaboration-on-advanced-therapies The Karolinska ATMP Center — a collaboration between Karolinska Institutet (KI) and Karolinska University Hospital — and St. Erik Eye Hospital have signed a letter of intent to strengthen their partnership in research, development, and clinical trials of cell- and gene-based medicines, known as Advanced Therapy Medicinal Products (ATMPs). The goal is to accelerate the transition from research to clinical application, particularly for retinal diseases that currently lack effective treatments. Thu, 04 Sep 2025 15:12:36 +0200 https://news.ki.se/studies-how-visual-disorders-after-brain-injuries-can-be-improved-by-training Visual disorders following acquired brain injury are common and affect a person’s everyday activities and quality of life. Tony Pansell is exploring how vision can be improved again – with the help of visual rehabilitation. Meet one of the new professors of Karolinska Institutet who will participate in this year's installation ceremony at Aula Medica on 9 October. Tue, 02 Sep 2025 10:00:08 +0200 https://news.ki.se/pete-williams-new-professor-of-vision-science-through-generous-donation Pete Williams, senior lecturer and research group leader at the Department of Clinical Neuroscience, has been appointed professor of visual science. The professorship is funded by the Ulla and Ingemar Dahlberg Foundation and has the full name “Ulla and Ingemar Dahlberg's professorship in visual science with specialisation in ocular neurobiology”. Wed, 09 Jul 2025 13:45:31 +0200 https://news.ki.se/swedish-eye-cancer-research-in-the-lead-ranked-fifth-globally Research on uveal melanoma - the most common form of eye cancer in adults - at St. Erik Eye Hospital and Karolinska Institutet has been ranked fifth in the world according to the 2024 ScholarGPS ranking. Mon, 02 Jun 2025 17:51:41 +0200 https://news.ki.se/long-partnership-with-johnson-johnson-paves-way-for-therapies-of-the-future The partnership between Johnson & Johnson Innovative Medicine (J&J) and Karolinska Institutet (KI) marks this year a decade of joint initiatives for promoting the development of tomorrow’s therapies. This long-standing collaboration between industry and academy has given rise to significant scientific advances in several fields of medicine. Mon, 19 May 2025 13:32:10 +0200 https://news.ki.se/vitamin-supplements-slow-down-the-progression-of-glaucoma A vitamin supplement that improves metabolism in the eye appears to slow down damage to the optic nerve in glaucoma. Promising results have been published in the journal Cell Reports Medicine. The researchers behind the study have now started a clinical trial on patients. Thu, 08 May 2025 16:56:07 +0200 https://news.ki.se/james-tribble-phd-receives-2025-shaffer-research-prize-from-glaucoma-research-foundation The Shaffer Prize recognizes a researcher whose project best exemplifies the pursuit of innovative ideas in the quest to cure glaucoma. Tue, 04 Mar 2025 12:44:52 +0100 https://news.ki.se/breathing-and-vision-may-be-linked Researchers at Karolinska Institutet in Sweden have discovered a fundamental mechanism that affects the size of the pupil, namely our breathing. The study, published in The Journal of Physiology, shows that the pupil is smallest during inhalation and largest during exhalation – something that could affect our vision. Fri, 21 Feb 2025 12:17:50 +0100 https://news.ki.se/promobilia-supports-ki-research-on-treatments-for-age-related-visual-impairment Fellow-KI researchers Anders Kvanta and Fredrik Lanner have been awarded a grant of SEK 10 million from the Promobilia foundation to develop a treatment for inherited retinal diseases, such as retinitis pigmentosa (RP), and age-related macular degeneration (AMD). There is currently no effective therapies for these diseases, which are the main cause of blindness in the developed world. Fri, 31 Jan 2025 14:30:46 +0100 https://news.ki.se/glaucoma-researcher-pete-williams-receives-grant-from-american-foundation Pete Williams, researcher at Karolinska Institutet and St. Erik Eye Hospital, has been awarded a research grant from the American Glaucoma Foundation to develop a treatment for glaucoma and other eye diseases. With the grant of USD 75,000 (SEK 840,000), the Foundation wants to recognize groundbreaking, innovative glaucoma research. This is the second time Pete Williams has received the grant. Fri, 10 Jan 2025 16:56:34 +0100 https://news.ki.se/combined-screening-can-detect-liver-damage-in-diabetes-patients New research from Karolinska Institutet highlights the possibility of screening people with type 2 diabetes for liver damage at the same time as they undergo screening for eye disease. The study is published in Lancet Gastroenterology and Hepatology. Fri, 13 Dec 2024 00:30:10 +0100 https://news.ki.se/gene-therapy-effective-in-hereditary-blindness Bothnia dystrophy is a form of hereditary blindness, prevalent in the region Västerbotten in Sweden. A new study at Karolinska Institutet published in Nature Communications shows that gene therapy can improve vision in patients with the disease. Tue, 10 Sep 2024 13:56:26 +0200 https://news.ki.se/the-search-for-an-effective-treatment-for-glaucoma Pete Williams is one of few researchers in Sweden concentrating on glauComa. The goal is an effective treatment, something that stops the degenerative process in the nerve cells of the eye. Wed, 07 Aug 2024 16:13:13 +0200 https://news.ki.se/generous-donation-to-eye-research-at-ki The Ulla and Ingemar Dahlberg Foundation has decided to donate SEK 50 million to Karolinska Institutet. The grant will be used for a new professorship in vision science with a focus on ocular neurobiology and have the full name "Ulla och Ingemar Dahlbergs professur i synvetenskap med inriktning mot okulär neurobiologi" (Ulla and Ingemar Dahlberg's Professorship in Visual Science with specialization in Ocular Neurobiology). Thu, 21 Dec 2023 16:20:07 +0100 https://news.ki.se/ki-researchers-anders-kvanta-and-fredrik-lanner-awarded-a-sek-10-million-grant KI researchers Anders Kvanta and Fredrik Lanner have been awarded a grant of SEK 10 million from the Erling-Persson Foundation for a clinical phase 1 trial on macular degeneration, a common age-related eye disease. By transplanting retinal cells from embryonic stem cells, the researchers hope to curb any further loss of vision and ultimately recover lost sight. Tue, 07 Nov 2023 13:39:19 +0100 https://news.ki.se/clinical-training-clinic-at-optometry-program-wins-the-klok-award-2023 This year's KLOK award goes to the Optometry program, which together with the St. Erik Eye Hospital has developed a clinical training clinic where students from several educational programs can broaden and deepen their knowledge in an interprofessional learning environment. Thu, 28 Sep 2023 17:33:17 +0200 https://news.ki.se/blind-people-sense-their-heartbeats-better-than-sighted Blind people are better at sensing their own heartbeats than sighted, shows a study by researchers at Karolinska Institutet in Sweden and Jagiellonian University in Poland. The study indicates that blindness leads to a heightened ability in feeling signals from the inner body. The findings are published in the Journal of Experimental Psychology: General. Fri, 24 Mar 2023 11:45:39 +0100 https://news.ki.se/new-study-on-vitamin-b3-as-a-possible-treatment-for-glaucoma Glaucoma involves a high risk of losing sight. Researchers at Karolinska Institutet and St. Erik Eye Hospital, among others, have now studied the effects of nicotinamide, the amide of vitamin B₃, on animal and cell models for glaucoma. The study, published in Redox Biology, may be a future neuroprotective therapy in glaucoma in humans. A clinical trial will start in the autumn. Mon, 17 May 2021 13:10:37 +0200 https://news.ki.se/hopes-of-new-treatment-strategies-for-glaucoma In the search for new ways to treat the incurable eye disease glaucoma, researchers at Karolinska Institutet and St. Erik Eye Hospital have discovered more clues as to its pathogenesis. A new study shows how metabolic disturbance of the neurons coincide with raised pressure in the eye. In animal and cell models, rapamycin and pyruvate treatments were shown to have a protective effect. The study is published in the journal PNAS. Tue, 15 Dec 2020 09:45:01 +0100 https://news.ki.se/karolinska-institutet-st-erik-eye-hospital-and-novo-nordisk-collaborate-to-find-a-cure-for-age-related-macular-degeneration Karolinska Institutet and St. Erik Eye Hospital have entered into a collaboration with Novo Nordisk A/S to develop a new treatment for age-related macular degeneration. Novo Nordisk A/S will provide support and SEK 48 million in funding to enable a phase 1 clinical trial where new retinal cells generated from embryonic stem cells will be transplanted into patients. The aim is to develop a completely new cell therapy for this common but currently incurable eye disease. Mon, 24 Aug 2020 12:00:00 +0200 https://news.ki.se/advances-in-production-of-retinal-cells-for-treating-blindness Researchers at Karolinska Institutet and St Erik Eye Hospital in Sweden have discovered a way to refine the production of retinal cells from embryonic stem cells for treating blindness in the elderly. Using the CRISPR/Cas9 gene editing, they have also managed to modify the cells so that they can hide from the immune system to prevent rejection. The studies are published in the scientific journals Nature Communications and Stem Cell Reports. Mon, 30 Mar 2020 11:00:06 +0200